GlobeNewsWire · SITC · October 29, 2026

Candel Therapeutics Announces Late-Breaking Abstract Accepted for Poster Presentation at the SITC 2026 Annual Meeting, Featuring Aglatimagene Besadenovec Data in Localized Prostate Cancer

Get the app for more

Explore stock news, insights and company research.